Scholars Central

Review articlePublished 18 May 2022

Re-Detectable Sars-CoV-2-An Emerging Problem in Recovered Sars-CoV-2 Patients in COVID Pandemic

Authors: Jyotsna Agarwal, Jaya Garg

Medical Case Reports

Volume 8 · Issue 5 · Pages 1–8

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Re-positive or Re-detectable SARS-CoV-2 (RD SARS-CoV-2) in recovered COVID-19 patients is a major issue in containment of COVID pandemic at present. This can be classified as real-time reverse transcription-PCR (RT-PCR) interpretation fault (false-negative or false-positive RT-PCR tests), re-activation or relapse of dormant virus or re-infection with SARS-CoV-2 either same or different variant. Though the literature has many documented cases on RD SARS-CoV-2 but the true epidemiology, etiology, clinico-demography, pathophysiology, and outcome of these cases are yet to be elucidated. To define RD SARS-CoV-2 it’s important to understand the standard discharge criteria for SARS-CoV-2 patients which include both the test based and the symptom based strategy. Currently, the WHO criteria and CDC criteria for releasing COVID-19 patients from isolation without requiring re-testing specify, 10days of period after a positive test for SARS-CoV-2 in asymptomatic patients; while in symptomatic cases, patient should have at least three additional symptom-free days.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMedical Case Reports
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Jyotsna Agarwal”
  • BylineArticles whose byline prints “Jaya Garg”